Roche’s Parkinson’s Drug Candidate Misses Key Goal in Mid-Stage Study

by | Dec 19, 2024 | Business

An experimental Parkinson’s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments for the neurodegenerative condition.

Article Attribution | Read More at Article Source